AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $504,000 | -69.8% | 702,647 | -4.8% | 0.00% | -66.7% |
| Q4 2021 | $1,668,000 | -14.1% | 738,075 | +9.5% | 0.01% | -30.8% |
| Q3 2021 | $1,941,000 | -13.9% | 673,939 | +13.3% | 0.01% | -7.1% |
| Q2 2021 | $2,255,000 | -27.8% | 594,946 | -35.5% | 0.01% | -33.3% |
| Q1 2021 | $3,124,000 | +279.6% | 922,954 | +213.9% | 0.02% | +162.5% |
| Q4 2020 | $823,000 | -36.3% | 294,029 | -42.8% | 0.01% | -50.0% |
| Q3 2020 | $1,291,000 | +121.8% | 514,236 | +1099.4% | 0.02% | +100.0% |
| Q2 2020 | $582,000 | +61.2% | 42,874 | -25.0% | 0.01% | +33.3% |
| Q4 2019 | $361,000 | -31.6% | 57,128 | -57.6% | 0.01% | -25.0% |
| Q3 2019 | $528,000 | -63.6% | 134,816 | -55.1% | 0.01% | -69.2% |
| Q2 2019 | $1,452,000 | +41.4% | 299,931 | +139.2% | 0.03% | +52.9% |
| Q1 2019 | $1,027,000 | – | 125,391 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |